Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.

Mowry, E M; Pelletier, D; Gao, Z; Howell, M D; Zamvil, S S; Waubant, E

Mowry, E M; Pelletier, D; Gao, Z; Howell, M D; Zamvil, S S; Waubant, E.

Affiliation

Mowry EM; Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pelletier D; Neurology, Yale University School of Medicine, New Haven, CT, USA.
Gao Z; Immune Tolerance Network, Bethesda, MD, USA.
Howell MD; Immune Tolerance Network, Bethesda, MD, USA.
Zamvil SS; Neurology, University of California, San Francisco, San Francisco, CA, USA.
Waubant E; Neurology, University of California, San Francisco, San Francisco, CA, USA.

Eur J Neurol ; 23(2): 327-32, 2016 Feb.

Article in En | MEDLINE | ID: mdl-26518224

Subject(s)

Demyelinating Diseases/blood; Demyelinating Diseases/pathology; Gray Matter/pathology; Neuroprotection; Vitamin D/analogs & derivatives; Adult; Clinical Trials, Phase II as Topic; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin D/blood

Key words

demyelinating disease; epidemiology; magnetic resonance imaging; multiple sclerosis; neurodegenerative disorders

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitamin D / Demyelinating Diseases / Gray Matter / Neuroprotection Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google